Close Menu
Invest Insider News
    Facebook X (Twitter) Instagram
    Thursday, November 19
    Facebook X (Twitter) Instagram Pinterest Vimeo
    Invest Insider News
    • Home
    • Bitcoin
    • Commodities
    • Finance
    • Investing
    • Property
    • Stock Market
    • Utilities
    Invest Insider News
    Home»Property»Astellas China exec lauds innovation-boosting policies
    Property

    Astellas China exec lauds innovation-boosting policies

    March 10, 20253 Mins Read


    Shirley Zhao, president of Astellas China

    China”s ongoing push for high-level opening-up, coupled with its enormous market potential and enhanced intellectual property protections, has fostered a conducive environment for multinational pharmaceutical companies to bring their innovation medical solutions to the country, said a senior executive.

    “We appreciate the Chinese government’s strong commitment to deepening reforms and expanding high-standard opening-up, with a slew of measures aimed at further optimizing the foreign investment environment,” said Shirley Zhao, president of Astellas China, in an exclusive interview with China Daily.

    Zhao’s comments followed the Government Work Report released at the two sessions – the annual meetings of China’s top legislative and political advisory bodies – which highlighted that the country “will keep working to foster a first-rate business environment that is market-oriented, law-based and internationalized, thus enabling foreign-funded enterprises to achieve even greater business success in China.”

    “As a multinational pharmaceutical company, Astellas has benefited from these supportive policies in its business growth in China, and we remain confident in the country’s continuous endeavors to improve the foreign investment environment,” Zhao added.

    Astellas has been deeply rooted in the Chinese market for thirty years, witnessing the transformation of its healthcare industry from a phase of importing products and technologies to high-quality development driven by innovation. Over the past three decades, China’s pharmaceutical innovation has made a historical leap, Zhao said.

    As the second-largest pharmaceutical market in the world, Zhao stressed that China is very important for Astellas, offering enormous market potential and opportunities for the company to leverage global expertise in accelerating innovation here.

    With China’s steady economic growth and rising living standards, the public demand for innovative medical solutions is increasing, particularly in oncology and other major disease areas, Zhao said.

    Over the past year, Astellas China, according to Zhao, has achieved key milestones in four disease areas, including gastric cancer, urothelial carcinoma, prostate cancer and vasomotor symptoms associated with menopause. The company has also experienced growth in size.

    Meanwhile, the Chinese government is actively accelerating the approval of innovative drugs, and improving the multi-layer medical security system. These efforts have created significant opportunities for Astellas’ development in China, Zhao said.

    “We are actively exploring collaborations with local partners to advance innovative drug development and clinical trials, contributing to China’s pharmaceutical innovation ecosystem,” Zhao said.

    “We look forward to more favorable policies of accelerating innovation, enhancing intellectual property protection, and improving patient access to innovation. Together, we aim to drive the high-quality development of China’s pharmaceutical and healthcare industry, serving the growing health needs of the Chinese population,” Zhao said.



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleLondon set to miss out on €20bn float of security group Verisure | Money News
    Next Article Quand l’argent des contribuables finance le luxe

    Related Posts

    Property

    Title insurance enables £156,000 bridging loan in 10 days

    November 19, 2026
    Property

    18-acre Suffolk site presents “Unique opportunity” for buyers

    November 19, 2026
    Property

    Greece’s 2027 Property Tax: Who Qualifies for Discounts and Exemptions?

    November 19, 2026
    Leave A Reply Cancel Reply

    Top Posts

    How is the UK Commercial Property Market Performing?

    December 31, 2000

    How much are they in different states across the US?

    December 31, 2000

    A Guide To Becoming A Property Developer

    December 31, 2000
    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • WhatsApp
    • Twitter
    • Instagram
    Latest Reviews
    Finance

    VIDEO: Experts Map Out the Current Investment and Finance Landscape

    October 30, 2024
    Bitcoin

    Binance Bitcoin/Stablecoin Ratio Signals Rising Buying Power as $1B Reserve Shift Mirrors March Rally Pattern

    January 5, 2026
    Property

    Excellence Commercial Property & Facilities Management Group Limited approuve le dividende final pour l’exercice clos le 31 décembre 2024

    May 27, 2025
    What's Hot

    Best Crypto to Buy Now: Strategy Just Spent $1.57 Billion on Bitcoin During Fear While Early Investors Quietly Enter Pepeto for 150x Potential

    March 21, 2026

    Bitcoin Decouples from Nasdaq: What It Means for Investors in 2026

    April 20, 2026

    Bitcoin Falls to February Levels as Standard Chartered Eyes Bottom

    June 4, 2026
    Most Popular

    Rightmove launches next phase of AI-powered property search

    February 12, 2026

    IBM acquires Prescinto to bolster renewable energy asset management capabilities

    October 18, 2024

    Lloyds: Strong Profit and Stable Credit Quality Support Earnings Outlook

    April 29, 2026
    Editor's Picks

    Bitcoin Price Tests $63K Support as $64K Reclaim Becomes Critical

    August 14, 2026

    Asian shares are mostly lower after US stocks retreat

    October 7, 2025

    North west claims law firm opens new front in motor finance battle as FCA admits redress scheme is delayed

    June 16, 2026
    Facebook X (Twitter) Instagram Pinterest Vimeo
    • Get In Touch
    • Privacy Policy
    • Terms and Conditions
    © 2026 Invest Insider News

    Type above and press Enter to search. Press Esc to cancel.